MYLAN-NITRO PATCH 0.2 DIN 02407442
Health Canada record
| Active ingredient(s) | NITROGLYCERIN 0.2 MG |
|---|---|
| Dosage form | Patch (Extended-Release) |
| Route | Transdermal |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C01DA02 GLYCERYL TRINITRATE |
| Original market date | 04-Jun-2013 |
| Current status date | 04-Jun-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NITROGLYCERIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02407450 | MYLAN-NITRO PATCH 0.4 | MYLAN PHARMACEUTICALS ULC | Patch (Extended-Release) | NITROGLYCERIN 0.4 MG | Marketed |
| 02407469 | MYLAN-NITRO PATCH 0.6 | MYLAN PHARMACEUTICALS ULC | Patch (Extended-Release) | NITROGLYCERIN 0.6 MG | Marketed |
| 02407477 | MYLAN-NITRO PATCH 0.8 | MYLAN PHARMACEUTICALS ULC | Patch (Extended-Release) | NITROGLYCERIN 0.8 MG | Marketed |
| 01911910 | NITRO-DUR 0.2 | USPHARMA LTD | Patch (Extended-Release) | NITROGLYCERIN 0.2 MG | Marketed |
| 01911902 | NITRO-DUR 0.4 | USPHARMA LTD | Patch (Extended-Release) | NITROGLYCERIN 0.4 MG | Marketed |
| 01911929 | NITRO-DUR 0.6 | USPHARMA LTD | Patch (Extended-Release) | NITROGLYCERIN 0.6 MG | Marketed |
| 02011271 | NITRO-DUR 0.8 | USPHARMA LTD | Patch (Extended-Release) | NITROGLYCERIN 0.8 MG | Marketed |
| 02145308 | NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML | BAXTER CORPORATION | Solution | NITROGLYCERIN 20 MG; DEXTROSE 5 G | Marketed |
| 02145316 | NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | BAXTER CORPORATION | Solution | NITROGLYCERIN 40 MG; DEXTROSE 5 G | Marketed |
| 02541033 | NITROGLYCERIN INJECTION USP | MONT-PHARMA INC | Solution | NITROGLYCERIN 50 MG | Approved |
| 00778869 | NITROJECT | JUNO PHARMA CANADA INC. | Solution | NITROGLYCERIN 50 MG | Marketed |
| 02231441 | NITROLINGUAL PUMPSPRAY | G POHL-BOSKAMP GMBH & CO KG | Metered-Dose Pump | NITROGLYCERIN 0.4 MG | Marketed |
| 00037613 | NITROSTAT | BGP PHARMA ULC | Tablet | NITROGLYCERIN 0.3 MG | Marketed |
| 00037621 | NITROSTAT | BGP PHARMA ULC | Tablet | NITROGLYCERIN 0.6 MG | Marketed |
| 02238998 | RHO-NITRO PUMPSPRAY | SANDOZ CANADA INCORPORATED | Metered-Dose Pump | NITROGLYCERIN 0.4 MG | Marketed |
| 02230732 | TRINIPATCH 0.2 | KNIGHT THERAPEUTICS INC. | Patch | NITROGLYCERIN 0.2 MG | Marketed |
| 02230733 | TRINIPATCH 0.4 | KNIGHT THERAPEUTICS INC. | Patch | NITROGLYCERIN 0.4 MG | Marketed |
| 02230734 | TRINIPATCH 0.6 | KNIGHT THERAPEUTICS INC. | Patch | NITROGLYCERIN 0.6 MG | Marketed |
| 02393433 | APO-NITROGLYCERIN | APOTEX INC | Metered-Dose Pump | NITROGLYCERIN 0.4 MG | Dormant |
| 02234518 | GLONOINUM | DOLISOS CANADA INC. | Granules; Liquid; Globules | NITROGLYCERIN 6 X | Cancelled Post Market |
| 02233766 | GLONOINUM | SEROYAL INTERNATIONAL INC. | Tablet; Globules; Pellet; Granules; Liquid; Drops | NITROGLYCERIN 6 X | Cancelled Post Market |
| 02233993 | GLONOINUM | HOMEOCAN INC. | Drops; Globules; Granules | NITROGLYCERIN 6 X | Cancelled Post Market |
| 02108283 | GLONOINUM - TAB (6X-30CH) | HOMEOCAN INC. | Tablet | NITROGLYCERIN 6 X | Cancelled Post Market |
| 00667692 | GLONOINUM DROPS 4CH-30CH | DOLISOS LABORATOIRES S.A. | Drops | NITROGLYCERIN 2 CH | Cancelled Post Market |
| 02073404 | HOMEOPATHIC MEDICINE (S NO. 54) DPS 30C | TOTAL HEALTH CENTRE | Drops | NITROGLYCERIN 30 C | Cancelled Post Market |
| 02163535 | MINITRAN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Patch | NITROGLYCERIN 0.6 MG | Cancelled Post Market |
| 02162806 | MINITRAN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Patch | NITROGLYCERIN 0.2 MG | Cancelled Post Market |
| 02163527 | MINITRAN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Patch | NITROGLYCERIN 0.4 MG | Cancelled Post Market |
| 02164337 | MINITRAN - PATCH TRD 72MG/26.6 SQ CM | GRACEWAY PHARMACEUTICALS | Patch | NITROGLYCERIN 72 MG | Cancelled (Unreturned Annual) |
| 02243588 | MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Metered-Dose Aerosol | NITROGLYCERIN 0.4 MG | Cancelled Post Market |
| 02213370 | NITRO-DUR 0.3 - 60MG/15 SQ CM, 0.3MG/HR | KEY PHARMACEUTICALS, DIVISION OF SCHERING PLOUGH CANADA INC. | Patch (Extended-Release) | NITROGLYCERIN 60 MG | Cancelled Post Market |
| 00749362 | NITROGARD-SR TAB 1MG | ASTRA PHARMA INC. | Tablet (Extended-Release) | NITROGLYCERIN 1 MG | Cancelled Post Market |
| 02145294 | NITROGLYCERIN IN 5% DEXTROSE INJ.-100MCG/ML | BAXTER CORPORATION | Solution | NITROGLYCERIN 10 MG; DEXTROSE 5 G | Cancelled Post Market |
| 00754188 | NITROGLYCERIN INJ 5MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | NITROGLYCERIN 5 MG | Cancelled Post Market |
| 00860778 | NITROGLYCERIN INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | NITROGLYCERIN 50 MG | Cancelled Post Market |
| 00614262 | NITROJECT INJ 1MG/ML | OMEGA LABORATORIES LIMITED | Solution | NITROGLYCERIN 10 MG | Cancelled Post Market |
| 01926454 | NITROL | PALADIN PHARMA INC. | Ointment | NITROGLYCERIN 2 % | Cancelled Post Market |
| 01926721 | NITROLINGUAL SPRAY 0.4MG/EAM | AVENTIS PHARMA INC | Metered-Dose Aerosol | NITROGLYCERIN 0.4 MG | Cancelled Post Market |
| 01927809 | NITRONG SR SRT 2.6MG | METRO PHARM INC. | Tablet (Extended-Release) | NITROGLYCERIN 2.6 MG | Cancelled Post Market |
| 00584223 | TRANSDERM-NITRO 0.2 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | NITROGLYCERIN 0.2 MG | Cancelled Post Market |
| 00852384 | TRANSDERM-NITRO 0.4 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | NITROGLYCERIN 0.4 MG | Cancelled Post Market |
| 02046156 | TRANSDERM-NITRO 0.6 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | NITROGLYCERIN 0.6 MG | Cancelled Post Market |
| 02046164 | TRANSDERM-NITRO 0.8 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | NITROGLYCERIN 100 MG | Cancelled Post Market |
| 01913921 | TRIDIL INJECTION 5MG/ML | DUPONT PHARMA INC. | Liquid | NITROGLYCERIN 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14420 | 2013-06-04 | Abbreviated New Drug Submission (ANDS) |
International API supply for NITROGLYCERIN
15 active FDA Drug Master Files.
Request a quote for MYLAN-NITRO PATCH 0.2